Patents Represented by Attorney Boziceic, Field & Francis LLP
  • Patent number: 7781179
    Abstract: Transitional cell carcinoma stem cells (TCCSC) are identified. The cells can be prospectively isolated or identified from primary tumor samples, and are shown to possess the unique properties of cancer stem cells in functional assays for cancer stem cell self-renewal and differentiation, and in cancer diagnosis.
    Type: Grant
    Filed: December 7, 2007
    Date of Patent: August 24, 2010
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Irving L. Weissman, Keith S. Chan